Showing 741-750 of 853 results for "".
- ISPA to Issue Guidance on Reopening Spas after the COVID-19 Pandemichttps://modernaesthetics.com/news/ispa-to-issue-guidance-on-reopening-spas-after-the-covid-19-pandemic/2472914/The International SPA Association (ISPA) is developing guidance for spas looking to reopen their doors after the COVID-19 pandemic. The resources will include updated sanitation and hygiene standards for the spa industry, checklists for reopening preparedness and employee education
- COVID-19 By the Numbers: April 7 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-7-edition-1/2472907/The peak for medical resource utilization related to COVID-19 in the US is estimated to hit on April 15, and deaths will peak on April 16, according to the Institute for Health Metrics and Evaluation (IHME), an independent population health research center at UW Medicine at the University of
- FDA Clears Wontech’s Sandro Dual Laserhttps://modernaesthetics.com/news/fda-clears-wontechs-sandro-dual-laser/2472905/The U.S. Food and Drug Administration granted 510 (K) marketing clearance to Wontech’s Sandro Dual, a hybrid Nd:YAG & Alexandrite laser device. In the hybrid mode, by irradiating a short time difference between two wavelengths of 755nm and 1064nm, the laser accurately hits its
- Meet Zaffiro, Neauvia’s Two-Part Solution to Skin Rejuvenationhttps://modernaesthetics.com/news/meet-zaffiro-neuvias-two-part-solution-to-skin-rejuvenation/2472893/Neauvia introduced Zaffiro to the media at an event held in New York City’s Hudson Yards, featuring New York City dermatologist Amy Lewis, MD Launched in the US in late 2019, the Zaffiro device is a dual facial rejuvenation system combining wa
- BTL Suit Alleges False Advertising by Allerganhttps://modernaesthetics.com/news/btl-suit-alleges-false-advertising-by-allergan-1/2472885/In a new lawsuit filed this week, BTL Industries alleges that Allergan launched a wide-ranging false and misleading advertising campaign relating to BTL's EMSCULPT device for non-invasive muscle toning and body shaping. The suit alleges that Allergan's marketing, sales materials, and soci
- Get Ready for Allergan's New DTC Juvéderm Lips Campaignhttps://modernaesthetics.com/news/get-ready-for-allergans-new-dtc-juvederm-lips-campaign/2472882/Allergan is launching its new direct-to-consumer campaign for Juvéderm lips with ads and creative deploying across TV, social media, and digital advertising. As part of the new campaign, New York City-based facial plastic surgeon Dara Liotta, MD, reality television personality Au
- RealSelf Reveals List of Most Worth It Procedureshttps://modernaesthetics.com/news/realself-reveals-list-of-most-worth-it-procedures/2472877/A total of 15 nonsurgical and 37 surgical procedures earned Real Self’s Most Worth It designation for 2020. The RealSelf Worth It Rating is a proprietary consumer satisfaction score based on reviews from consumers on RealSelf who, after undergoing a treatment, rated it as "Wo
- SkinMedica's DiamondGlow Hits Doctor's Officeshttps://modernaesthetics.com/news/skinmedicas-diamondglow-hits-doctors-offices/2472875/llergan’s Skinmedica is rolling out DiamondGlow, a non-invasive dermabrasion technology that exfoliates, extracts, and treats the face, eye area, lips and body. Allergan acquired Envy Medical, Inc and its Silkpeel&nbs
- Most Plastic Surgery YouTube and Social Media Videos Are Poor Qualityhttps://modernaesthetics.com/news/most-plastic-surgery-youtube-and-social-media-videos-are-poor-quality/2472874/YouTube and social media videos aren't necessarily the most reliable source of plastic surgery information, concludes a study in the February issue of Plastic and Reconstructive Surgery. Despite this, a recent American So
- New Data from Revian Red: System Shown to Support Hair Growthhttps://modernaesthetics.com/news/new-data-from-revian-red-system-shown-to-support-hair-growth/2472868/The Revian Red hair growth system demonstrates the ability to successfully stop hair loss and subsequently grow new hair, according to final data from a randomized, double-blind study. Findings were presented at the 2020 Winter Clinical Dermatology Conference – Hawaii an